Europe’s medicines watchdog publishes new report identifying COVID-19 lessons learned

The European Medicines Agency (EMA) approved vaccines and treatments for COVID-19 in 2021 and strengthened its cyber-capabilities after a 2020 attack. It also extended its mandate and worked on developing a data analysis network. The agency acknowledged the need to improve data collection and coordination and enhance public trust in vaccines. Digital developments, such as AI and machine learning, were central to its activities. The EMA faced a cyber-attack but managed to contain it without affecting its operations. It aims to be prepared for future health threats.